Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Article
  • Published:

A point mutation in the extracellular domain of L1 blocks its capacity to confer metastasis in colon cancer cells via CD10

Subjects

Abstract

The neural L1 transmembrane cell adhesion receptor of the immunoglobulin-like family is a target gene of Wnt-β-catenin signaling in human colorectal cancer (CRC) cells and is expressed at the invasive edge of the tumor tissue. L1 overexpression in cultured CRC cells confers enhanced proliferation, motility and liver metastasis. We have analyzed the mechanisms of L1-mediated signaling in CRC cells by using various point mutations in the L1 ectodomain that are known to cause severe genetically inherited mental retardation disorders in patients. We found that all such L1 ectodomain mutations abolish the ability of L1 to confer metastatic properties in CRC cells. Using gene array analysis, we identified L1-mutation-specific gene expression signatures for the L1/H210Q and L1/D598N mutations. We identified CD10, a metalloprotease (neprilysin, neutral endopeptidase) and a gene that is specifically induced in CRC cells by L1 in an L1/H210Q mutation-specific manner. CD10 expression was required for the L1-mediated induction of cell proliferation, motility and metastasis, as suppression of CD10 levels in L1-expressing CRC cells abolished the L1 effects on CRC progression. The signaling from L1 to CD10 was mediated through the L1-ezrin-NF-κB pathway. In human CRC tissue L1 and CD10 were localized in partially overlapping regions in the more invasive areas of the tumor tissue. The results suggest that CD10 is a necessary component conferring the L1 effects in CRC cells. The identification of gene expression patterns of L1-domain-specific point mutations may provide novel markers and targets for interfering with L1-mediated CRC progression.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2
Figure 3
Figure 4
Figure 5
Figure 6
Figure 7

Similar content being viewed by others

References

  1. Grumet M . Cell adhesion molecules and their subgroups in the nervous system. Curr Opin Neurobiol 1991; 1: 370–376.

    Article  CAS  PubMed  Google Scholar 

  2. Chang S, Rathjen FG, Raper JA . Extension of neurites on axons is impaired by antibodies against specific neural cell surface glycoproteins. J Cell Biol 1987; 104: 355–362.

    Article  CAS  PubMed  Google Scholar 

  3. Rathjen FG, Wolff JM, Frank R, Bonhoeffer F, Rutishauser U . Membrane glycoproteins involved in neurite fasciculation. J Cell Biol 1987; 104: 343–353.

    Article  CAS  PubMed  Google Scholar 

  4. Lemmon V, Farr KL, Lagenaur C . L1-mediated axon outgrowth occurs via a homophilic binding mechanism. Neuron 1989; 2: 1597–1603.

    Article  CAS  PubMed  Google Scholar 

  5. Friedlander DR, Milev P, Karthikeyan L, Margolis RK, Margolis RU, Grumet M . The neuronal chondroitin sulfate proteoglycan neurocan binds to the neural cell adhesion molecules Ng-CAM/L1/NILE and N-CAM, and inhibits neuronal adhesion and neurite outgrowth. J Cell Biol 1994; 125: 669–680.

    Article  CAS  PubMed  Google Scholar 

  6. Cohen NR, Taylor JS, Scott LB, Guillery RW, Soriano P, Furley AJ . Errors in corticospinal axon guidance in mice lacking the neural cell adhesion molecule L1. Curr Biol 1998; 8: 26–33.

    Article  CAS  PubMed  Google Scholar 

  7. Jouet M, Rosenthal A, Armstrong G, MacFarlane J, Stevenson R, Paterson J et al. X-linked spastic paraplegia (SPG1), MASA syndrome and X-linked hydrocephalus result from mutations in the L1 gene. Nat Genet 1994; 7: 402–407.

    Article  CAS  PubMed  Google Scholar 

  8. Wong EV, Kenwrick S, Willems P, Lemmon V . Mutations in the cell adhesion molecule L1 cause mental retardation. Trends Neurosci 1995; 18: 168–172.

    Article  CAS  PubMed  Google Scholar 

  9. Kamiguchi H, Hlavin ML, Lemmon V . Role of L1 in neural development: what the knockouts tell us. Mol Cell Neurosci 1998; 12: 48–55.

    Article  CAS  PubMed  Google Scholar 

  10. Conacci-Sorrell ME, Ben-Yedidia T, Shtutman M, Feinstein E, Einat P, Ben-Ze'ev A . Nr-CAM is a target gene of the beta-catenin/LEF-1 pathway in melanoma and colon cancer and its expression enhances motility and confers tumorigenesis. Genes Dev 2002; 16: 2058–2072.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  11. Gavert N, Conacci-Sorrell M, Gast D, Schneider A, Altevogt P, Brabletz T et al. L1, a novel target of beta-catenin signaling, transforms cells and is expressed at the invasive front of colon cancers. J Cell Biol 2005; 168: 633–642.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  12. Gavert N, Sheffer M, Raveh S, Spaderna S, Shtutman M, Brabletz T et al. Expression of L1-CAM and ADAM10 in human colon cancer cells induces metastasis. Cancer Res 2007; 67: 7703–7712.

    Article  CAS  PubMed  Google Scholar 

  13. Gavert N, Ben-Shmuel A, Lemmon V, Brabletz T, Ben-Ze'ev A . Nuclear factor-kappaB signaling and ezrin are essential for L1-mediated metastasis of colon cancer cells. J Cell Sci 2010; 123: 2135–2143.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  14. De Angelis E, MacFarlane J, Du JS, Yeo G, Hicks R, Rathjen FG et al. Pathological missense mutations of neural cell adhesion molecule L1 affect homophilic and heterophilic binding activities. EMBO J 1999; 18: 4744–4753.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  15. De Angelis E, Watkins A, Schafer M, Brummendorf T, Kenwrick S . Disease-associated mutations in L1 CAM interfere with ligand interactions and cell-surface expression. Hum Mol Genet 2002; 11: 1–12.

    Article  CAS  PubMed  Google Scholar 

  16. Beer S, Oleszewski M, Gutwein P, Geiger C, Altevogt P . Metalloproteinase-mediated release of the ectodomain of L1 adhesion molecule. J Cell Sci 1999; 112 (Pt 16): 2667–2675.

    CAS  PubMed  Google Scholar 

  17. Felding-Habermann B, Silletti S, Mei F, Siu CH, Yip PM, Brooks PC et al. A single immunoglobulin-like domain of the human neural cell adhesion molecule L1 supports adhesion by multiple vascular and platelet integrins. J Cell Biol 1997; 139: 1567–1581.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  18. Oleszewski M, Beer S, Katich S, Geiger C, Zeller Y, Rauch U et al. Integrin and neurocan binding to L1 involves distinct Ig domains. J Biol Chem 1999; 274: 24602–24610.

    Article  CAS  PubMed  Google Scholar 

  19. Shapiro B, Tocci P, Haase G, Gavert N, Ben-Ze'ev A . Clusterin, a gene enriched in intestinal stem cells, is required for L1-mediated colon cancer metastasis. Oncotarget 2015; 6: 34389–34401.

    Article  PubMed  PubMed Central  Google Scholar 

  20. Yao T, Takata M, Tustsumi S, Nishiyama K, Taguchi K, Nagai E et al. Phenotypic expression of gastrointestinal differentiation markers in colorectal adenocarcinomas with liver metastasis. Pathology 2002; 34: 556–560.

    Article  CAS  PubMed  Google Scholar 

  21. Ohji Y, Yao T, Eguchi T, Yamada T, Hirahashi M, Iida M et al. Evaluation of risk of liver metastasis in colorectal adenocarcinoma based on the combination of risk factors including CD10 expression: multivariate analysis of clinicopathological and immunohistochemical factors. Oncol Rep 2007; 17: 525–530.

    CAS  PubMed  Google Scholar 

  22. Koga Y, Yao T, Hirahashi M, Kumashiro Y, Ohji Y, Yamada T et al. Flat adenoma-carcinoma sequence with high-malignancy potential as demonstrated by CD10 and beta-catenin expression: a different pathway from the polypoid adenoma-carcinoma sequence. Histopathology 2008; 52: 569–577.

    Article  CAS  PubMed  Google Scholar 

  23. Maguer-Satta V, Besancon R, Bachelard-Cascales E . Concise review: neutral endopeptidase (CD10): a multifaceted environment actor in stem cells, physiological mechanisms, and cancer. Stem Cells 2011; 29: 389–396.

    Article  CAS  PubMed  Google Scholar 

  24. Ben-Shmuel A, Shvab A, Gavert N, Brabletz T, Ben-Ze'ev A . Global analysis of L1-transcriptomes identified IGFBP-2 as a target of ezrin and NF-kappaB signaling that promotes colon cancer progression. Oncogene 2013; 32: 3220–3230.

    Article  CAS  PubMed  Google Scholar 

  25. Malfroy B, Kuang WJ, Seeburg PH, Mason AJ, Schofield PR . Molecular cloning and amino acid sequence of human enkephalinase (neutral endopeptidase). FEBS Lett 1988; 229: 206–210.

    Article  CAS  PubMed  Google Scholar 

  26. Erdos EG, Skidgel RA . Neutral endopeptidase 24.11 (enkephalinase) and related regulators of peptide hormones. FASEB J 1989; 3: 145–151.

    Article  CAS  PubMed  Google Scholar 

  27. Ogawa H, Iwaya K, Izumi M, Kuroda M, Serizawa H, Koyanagi Y et al. Expression of CD10 by stromal cells during colorectal tumor development. Hum Pathol 2002; 33: 806–811.

    Article  PubMed  Google Scholar 

  28. Haspel J, Grumet M . The L1CAM extracellular region: a multi-domain protein with modular and cooperative binding modes. Front Biosci 2003; 8: s1210–s1225.

    Article  CAS  PubMed  Google Scholar 

  29. Silletti S, Yebra M, Perez B, Cirulli V, McMahon M, Montgomery AM . Extracellular signal-regulated kinase (ERK)-dependent gene expression contributes to L1 cell adhesion molecule-dependent motility and invasion. J Biol Chem 2004; 279: 28880–28888.

    Article  CAS  PubMed  Google Scholar 

  30. Schmid RS, Maness PF . L1 and NCAM adhesion molecules as signaling coreceptors in neuronal migration and process outgrowth. Curr Opin Neurobiol 2008; 18: 245–250.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  31. Gavert N, Shvab A, Sheffer M, Ben-Shmuel A, Haase G, Bakos E et al. c-Kit is suppressed in human colon cancer tissue and contributes to L1-mediated metastasis. Cancer Res 2013; 73: 5754–5763.

    Article  CAS  PubMed  Google Scholar 

  32. Hlavin ML, Lemmon V . Molecular structure and functional testing of human L1CAM: an interspecies comparison. Genomics 1991; 11: 416–423.

    Article  CAS  PubMed  Google Scholar 

  33. Brabletz T, Jung A, Dag S, Hlubek F, Kirchner T . beta-catenin regulates the expression of the matrix metalloproteinase-7 in human colorectal cancer. Am J Pathol 1999; 155: 1033–1038.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

Download references

Acknowledgements

We thank Drs N Iwata, M Shtutman, F Rathjen and V Lemmon for providing reagents. This study was supported by grants from the Israel Science Foundation (ISF) and from the Israel Cancer Research Fund (ICRF). A B-Z is the incumbent of the Lunenfeld-Kunin professorial chair in genetics and cell biology.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to A Ben-Ze'ev.

Ethics declarations

Competing interests

The authors declare no conflict of interest.

Additional information

Supplementary Information accompanies this paper on the Oncogene website

Supplementary information

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Haase, G., Gavert, N., Brabletz, T. et al. A point mutation in the extracellular domain of L1 blocks its capacity to confer metastasis in colon cancer cells via CD10. Oncogene 36, 1597–1606 (2017). https://doi.org/10.1038/onc.2016.329

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/onc.2016.329

This article is cited by

Search

Quick links